IVERIC bio: Funding, Investors & Team (Sep 2026)
IVERIC bio is a science-driven biopharmaceutical organization zeroed in on the revelation and improvement of novel therapy choices for retinal sicknesses with critical neglected clinical requirements. The Company is at present creating both helpful item possibility for age-related retinal illnesses and quality treatment item contender for vagrant acquired retinal sicknesses.
IVERIC bio has raised $250M across 1 funding round on record, the most recent a Post-IPO Debt of $250M announced in Jul 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
IVERIC bio Company Profile and Key Stats
Latest funding round on record: Jul 2022.
IVERIC bio Funding Rounds
IVERIC bio Founders and Leadership Team
Contact details for the IVERIC bio team: 1 of 1 has an email address on file.
Start 14-day free trial →IVERIC bio Funding Compared to Other Biotechnology Startups
IVERIC bio's latest round of $250M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like IVERIC bio in Biotechnology and Princeton
Companies Similar to IVERIC bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
IVERIC bio Funding FAQs
What does IVERIC bio do?
IVERIC bio is a science-driven biopharmaceutical organization zeroed in on the revelation and improvement of novel therapy choices for retinal sicknesses with critical neglected clinical requirements. The Company is at present creating both helpful item possibility for age-related retinal illnesses and quality treatment item contender for vagrant acquired retinal sicknesses.
How much funding has IVERIC bio raised?
IVERIC bio has raised $250M across 1 round on record. The most recent is a Post-IPO Debt of $250M announced in Jul 2022.
When did IVERIC bio last raise funding?
IVERIC bio's most recent funding round on record is a Post-IPO Debt of $250M, announced in Jul 2022.
Who is the CEO of IVERIC bio?
Glenn Sblendorio is listed as CEO at IVERIC bio.
Where is IVERIC bio headquartered?
IVERIC bio is based in Princeton, New Jersey, United States.
How many employees does IVERIC bio have?
IVERIC bio is in the 51-100 employee band.
How does IVERIC bio's funding compare to other Biotechnology startups?
IVERIC bio's latest round of $250M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's IVERIC bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for IVERIC bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.